NEW YORK (GenomeWeb News) – Affymetrix this week said it sold its Anatrace business to investment firm StoneCalibre for an undisclosed amount. Anatrace is based in Maumee, Ohio and is a highly specialized developer, manufacturer, and distributor of high-purity detergents and synthetic lipids used in membrane protein research. An Affymetrix spokesman said Anatrace's revenues were not material to the company's overall financials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.